Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion
NCT ID: NCT04242212
Last Updated: 2020-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2019-05-19
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria
NCT01539408
Study of Clinic-based Versus Self-use of Medical Abortion Pills
NCT03727308
Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
NCT04181541
Misoprostol for Management of Women With an Incomplete Miscarriage
NCT05088720
Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation
NCT02412618
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will prospectively recruit women who obtain misoprostol from patent medicine vendors and clinics. Follow-up will occur by telephone during three phone calls within 45 days of the first dose of misoprostol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinic-based
Women who get misoprostol from a clinic-based provider
Misoprostol sourced from clinics
One cohort of women using misoprostol sourced from clinics
PMV-based
Women who get misoprostol from a patent medicine vendor
Misoprostol sourced from PMVs
One cohort of women using misoprostol sourced from PMVs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol sourced from clinics
One cohort of women using misoprostol sourced from clinics
Misoprostol sourced from PMVs
One cohort of women using misoprostol sourced from PMVs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 15 years of age
* Have a known LMP of less than 9 weeks
* No contraindications to medical abortion
* Willing and able to give informed consent
* Have a mobile phone of which they are the independent user or be willing to be followed-up in person
* Willing to be contacted with questions about her abortion by telephone at 1-3, 10-29 and 30-45 days following initial contact.
Exclusion Criteria
* Age \<15 or \>49
15 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ipas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Multiple facilities
Awka, Anambra, Nigeria
Multiple facilities
Abeokuta, Ogun State, Nigeria
Multiple facilities
Ibadan, Oyo State, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ipas_NMAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.